Scale Medicine
New York, US · Founded 2023 · Delaware corporation · 1 known investors
Find your way into Scale Medicine
Sign up to see every warm intro you have to Scale Medicine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Scale Medicine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Scale Medicine is an AI-native pharmaceutical company that applies artificial intelligence to improve the success rates of its clinical trials.
Founders & leadership
MR
Michael RetchinNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2023
▶$2MraisedDec 2023 · 5 investors · OtherRule 506(b)
▶$2MraisedDec 2023 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael RetchinExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Scale Medicine do?
- Scale Medicine is an AI-native pharmaceutical company that applies artificial intelligence to improve the success rates of its clinical trials.
- Who are Scale Medicine's investors?
- Scale Medicine's investors include Amino Collective.
- How much funding has Scale Medicine raised?
- Scale Medicine has disclosed $2M raised across 1 round.
- Where is Scale Medicine headquartered?
- Scale Medicine is headquartered in New York, US.
